Proterozoic adr ~2.0 Gya #2

ADR-006 — Endosymbiotic Acquisition of Alphaproteobacterium for Aerobic ATP

see thread: ~2.0 Gya

ADR-006: Endosymbiotic Acquisition of Alphaproteobacterium for Aerobic ATP Production

Date: -2000000000-03-15T00:00:00Z Status: Accepted Deciders: The Architect, Gabriel, Raphael Related: ADR-003 (chemiosmosis), commit 7f3a1b9 (ATP synthase), INC-0240 (Great Oxidation Event)

Context

Aerobic respiration is currently being rolled out into the existing anaerobic archaeal lineage by horizontal gene transfer. Yield gains are real (~30 ATP/glucose actual versus 2 from substrate-level phosphorylation; ref ADR-003) but the rollout has been:

  1. Slow. ~600 My since INC-0240 mitigation began. Most lineages are not there yet.
  2. Inconsistent. Cytochrome c oxidase variants are diverging across archaeal genera. Maintenance is becoming intractable.
  3. Lossy. Reactive oxygen species (superoxide, peroxide, hydroxyl) generated as Complex I and Complex III electron leakage are damaging the genomic DNA we ship in the same compartment as the electron transport chain. We are corrupting our own source while running it.

We need to isolate the oxidative machinery from the host genome.

A candidate solution is already in the wild. Alphaproteobacterial lineages (Rickettsiales-adjacent) run aerobic respiration in their own membrane-bound compartment, with their own genome, and their own copy of ATP synthase (commit 7f3a1b9 lineage, ref ADR-003). Their compartmentalization solves the ROS isolation problem natively, because they evolved in atmospheric O₂ and their DNA repair budget is already sized for it.

Decision

Acquire one. We engulf an alphaproteobacterium via phagocytosis, do not digest it, and migrate its electron transport chain into production as a managed organelle.

The acquired organism retains:

  • Its inner membrane (will become the cristae)
  • Its electron transport chain (Complexes I–IV)
  • Its ATP synthase
  • A reduced genome (target: aggressive endosymbiotic gene transfer to the host nucleus over time)
  • Its own ribosomes (70S, kept distinct from host 80S)
  • Maternal-only inheritance pattern (emergent, see Consequences)

The acquired organism loses:

  • Cell wall
  • Most metabolic autonomy
  • Most of its genome (transferred to nucleus, deleted, or both)
  • All exit options

Consequences

Positive:

  • ROS generation is now compartmentalized. Damage is contained inside the organelle. The organelle’s small genome is what gets corroded, not the host nucleus.
  • Energy density jumps. Aerobic eukaryotes can now sustain genome sizes and cellular volumes that anaerobes cannot. Multicellularity becomes possible downstream. Not in this ADR.
  • We get a preinstalled, debugged ETC. We do not maintain it. We inherit the maintenance.

Negative:

  • We are inheriting a foreign codebase. Their gene regulation conventions differ from ours. Code review is going to be prolonged. By “prolonged” we mean indefinite.
  • Protein import becomes a hard problem. Most of the proteins the organelle needs will end up encoded in the nucleus. We will need a TOM/TIM translocation system to import them back into the compartment whose genes we just moved out. This is circular. We are aware. There is no other path.
  • The acquired genome carries group II self-splicing introns. These are migrating into the host genome. Splicing machinery is going to need to scale. Raphael flagged. Splicing is not in scope for this ADR. See CELL-2848.
  • Maternal-only inheritance of the organelle’s genome falls out of the cytoplasmic acquisition pattern. We did not design this. We are not undesigning it. Downstream genetic counseling tickets will reference this ADR for the next 2 Gy.
  • Integration is not, and will never be, complete. Two billion years from now there will still be 37 protein-coding-and-RNA genes in mitochondrial DNA that we have not been able to relocate to the nucleus. The retained genes are mostly hydrophobic inner-membrane components that the import machinery cannot handle. We have accepted this.

Alternatives Considered

  1. Build aerobic respiration natively into the archaeal lineage. Cost: ~1 Gy of additional rollout. Quality: lower — no preinstalled compartmentalization, ROS damage continues to hit the host genome. Rejected.

  2. Plastid-style acquisition of a cyanobacterium first, get carbon fixation as a bonus. Out of scope here. Cyanobacteria solve a different problem (carbon fixation, not ATP yield from organic substrate). Punted to ADR-007. We are aware that the text “we are not doing this again” appears below. ADR-007 will need to argue against it.

  3. Do nothing. Accept the 2 ATP/glucose ceiling indefinitely. Rejected by the Architect without comment.

Notes

Gabriel: The TOM/TIM translocation problem alone is going to generate tickets for the next 2 Gy. Approving anyway. We need the energy density and we need the ROS isolation. The integration cost is real but it is amortizable.

Raphael: Excited about this one. The cristae folding is going to be elegant once it stabilizes. The surface-area gain on the inner membrane gives us roughly an order of magnitude more ETC capacity per cell. I want to be in the room when we ship apoptosis on top of this — cytochrome c release as a kill signal is a beautiful reuse of the same component.

Michael: The energy budget is supportable at the ecosystem level. Entropy accounting is fine for this. No infrastructure changes needed.

The Architect: Approved. Note for the record: this is the last large acquisition we will do.